Roche to present data for TECENTRIQ (atezolizumab) from across its genitourinary and gastrointestinal cancer immunotherapy programme at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

Basel, 01 June 2018 Roche to present data for TECENTRIQ (atezolizumab) from across its genitourinary and gastrointestinal cancer immunotherapy programme at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting The data to be presented further demonstrate potential of TECENTRIQ and Avastin combination in renal cell carcinoma, a type of kidney cancer, and hepatocellular... Read more

Agilent and University of Duisburg-Essen Announce Collaboration Agreement

Agilent and University of Duisburg-Essen Announce Collaboration Agreement Construction Anticipates Future Growth in Genomics Market SANTA CLARA, Calif., May 24, 2018 Agilent Technologies Inc. (NYSE: A) Agilent Technologies Inc. (NYSE: A) and the University of Duisburg-Essen has formed a collaboration agreement that brings together Agilent’s leading analytical technologies with the University’s outstanding researchers. As part... Read more

QIAGEN launches the DNeasy PowerSoil Pro Kit to advance microbiome characterization in soils

Germantown, Maryland, and Hilden, Germany, May 23, 2018 – QIAGEN today announced the worldwide launch of the new DNeasy PowerSoil Pro Kit, the next generation of sample technology for the extraction of fungal and bacterial DNA from a range of soil samples. The new DNeasy PowerSoil Pro Kits featuring a streamlined version of QIAGEN’s proprietary... Read more

MTS Receives Energy Efficiency Award From Xcel Energy

EDEN PRAIRIE, Minn., May 21, 2018 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems and sensors, today announced receipt of a Recognition of Excellence Award for efforts to improve energy efficiency. MTS was recognized at the Xcel Energy Efficiency Expo for several energy-saving initiatives, from stopping compressed air loss... Read more

New Two-In-One Instrument Simplifies Flow Data Control in Oil and Gas Operations

Thermo Scientific AutoXP flow computer doubles as a smart multivariable transmitter, providing a common platform for multiple applications FRANKLIN, Mass., May 15, 2018 /PRNewswire/ — Field technicians, SCADA personnel and managers across all oil and gas industry sectors can now more easily generate, manage and interpret flow data with a new flow computer that incorporates... Read more

FDA approves subcutaneous formulation of Actemra for use in active polyarticular juvenile idiopathic arthritis (pJIA), a rare form of juvenile arthritis

Basel, 15 May 2018 FDA approves subcutaneous formulation of Actemra for use in active polyarticular juvenile idiopathic arthritis (pJIA), a rare form of juvenile arthritis Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved the subcutaneous (SC) formulation of Actemra® (tocilizumab) for the treatment of active... Read more

Elsevier Teams up With PerkinElmer to Enable Faster, More Intuitive Chemistry Research

First phase of a long-term collaboration set to improve the research experience by integrating flagship solutions ChemDraw and Reaxys New York, May 8, 2018 Elsevier, the information analytics business specializing in science and health, has today announced a strategic collaboration with PerkinElmer. The first phase of this collaboration will see the integration of Elsevier’s flagship chemistry... Read more

FDA grants priority review to Roche’s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer

Basel, 07 May 2018 FDA grants priority review to Roche’s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority... Read more

FDA grants priority review to Roche’s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer

Basel, 07 May 2018 FDA grants priority review to Roche’s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority... Read more

TAN/TBN titration in petrochemical samples – walk away automation for up to 112 samples

5/1/2018 Metrohm is pleased to present a fully automated solution for the determination of Total Acid Number (TAN) and Total Base Number (TBN) in up to 112 samples. This solution is based on the OMNIS Sample Robot and addresses the needs of QC laboratories in the petrochemical industry as well as contract laboratories looking for... Read more